Details
Role
Honorary Fellow
Top Publications
-
Ryland, GL, Umeda, M, Holmfeldt, L, Lehmann, S, Herlin, MK, Ma, J, Khanlari, M, Rubnitz, JE, Ries, RE, Kosasih, HJ, et al.
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions.
Blood
141(7)
:
800 -805
2023
view publication
-
Schmidt, B, Brown, LM, Ryland, GL, Lonsdale, A, Kosasih, HJ, Ludlow, LE, Majewski, IJ, Blombery, P, Ekert, PG, Davidson, NM, et al.
ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia.
Blood Advances
6(14)
:
4093 -4097
2022
view publication
-
Lewis, AC, Pope, VS, Tea, MN, Li, M, Nwosu, GO, Nguyen, TM, Wallington-Beddoe, CT, Moretti, PAB, Anderson, D, Creek, DJ, et al.
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.
Blood
139(26)
:
3737 -3751
2022
view publication
-
Kimura, S, Montefiori, L, Iacobucci, I, Zhao, Y, Gao, Q, Paietta, EM, Haferlach, C, Laird, AD, Mead, PE, Gu, Z, et al.
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Blood
139(24)
:
3519 -3531
2022
view publication
-
Brown, LM, Hediyeh-zadeh, S, Sadras, T, Huckstep, H, Sandow, JJ, Bartolo, RC, Kosasih, HJ, Davidson, NM, Schmidt, B, Bjelosevic, S, et al.
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
Blood Advances
6(7)
:
2373 -2387
2022
view publication
